SCHEMBL8450128

SCHEMBL8450128

[c]1nc2ccccc2n1Cc1ccco1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 7/20 0.49
ALDH1A1 P00352 6/20 0.49
HSD17B10 Q99714 5/20 0.49
USP2 O75604 4/20 0.49
KDM4E B2RXH2 4/20 0.49
ATM Q13315 1/20 0.43
SMN1; SMN2 Q16637 4/20 0.43
MAPK1 P28482 1/20 0.43
STAT3 P40763 1/20 0.43
TRPC4 Q9UBN4 1/20 0.41
TRPC5 Q9UL62 1/20 0.41
GAA P10253 2/20 0.40
HTT P42858 2/20 0.40
MEN1 O00255 2/20 0.40
MAPT P10636 2/20 0.40
HPGD P15428 2/20 0.40
KMT2A Q03164 2/20 0.40
THRB P10828 1/20 0.40
TP53 P04637 1/20 0.38
ALOX15 P16050 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8457471 0.76 HIF1A (0.38) ALDH1A1HSD17B10KDM4ESMN1; SMN2MAPK1
SCHEMBL9697111 0.76 NPC1 (0.46) TSHRALDH1A1HSD17B10KDM4ESMN1; SMN2
SCHEMBL356141 0.75 TNF (0.47) ALDH1A1SMN1; SMN2MEN1KMT2ACFTR
SCHEMBL5761994 0.75 ADORA3 (0.40) TSHRALDH1A1HSD17B10USP2KDM4E
SCHEMBL9696683 0.74 GRIN1 (0.37) ALDH1A1HSD17B10KDM4ESMN1; SMN2MAPK1
SCHEMBL4737092 0.71 SLC9A1 (0.34) ALDH1A1KDM4EATMSMN1; SMN2MAPK1
SCHEMBL944723 0.71 TDP1 (0.51) TSHRALDH1A1SMN1; SMN2MAPK1HTT
SCHEMBL1381878 0.71 SLC9A1 (0.44) TSHRALDH1A1HSD17B10USP2KDM4E
SCHEMBL2103982 0.71 POLB (0.39) TSHRALDH1A1KDM4EATMMAPK1
SCHEMBL945956 0.70 TNF (0.50) TSHRALDH1A1KDM4ESMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143856-C Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) [1,4] diazepan-1-yl)-1-(aryl) butyl) benzamides useful for treatment of allergic diseases ���µ�˹ҩ�﹫˾ 2004-03-31 CN disclosed
CN-1115341-C Novel substituted N-methyl-N- (4- (4- (1H-benzimidazol-2-ylamino) piperidin-1-yl) -2- (aryl) butyl) benzamides for the treatment of allergic diseases AVENTIS PHARMACEUTICALS CORP (US) 2003-07-23 CN disclosed
CN-1211248-A Novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) [1,4] diazepan-1-yl)-1-(aryl) butyl) benzamides useful for treatment of allergic diseases HOECHST MARION ROUSSEL INC (US) 1999-03-17 CN disclosed
CN-1211246-A Novel substituted N-methyl-N-(4-(1H-benzimidazol-2-yl-amino) piperidin-1-yl)-2-(aryl) butyl) benzamides useful for treatment of allergic diseases HOECHST MARION ROUSSEL INC (US) 1999-03-17 CN disclosed
EP-0888336-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL-AMINO)P IPERIDIN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1999-01-07 EP disclosed
WO-1997030989-A1 NOVEL SUBSTITUTED N-METHYL-N-(4-(4-(1H-BENZIMIDAZOL-2-YL-AMINO)PIPERIDIN-1-YL)-2-(ARYL)BUTYL)BENZAMIDES USEFUL FOR THE TREATMENT OF ALLERGIC DISEASES HOECHST MARION ROUSSEL, INC. (US) 1997-08-28 WO disclosed